The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 510.00
Bid: 509.00
Ask: 510.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.196%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 510.00
BAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of part of aerial emergency services business

19 Jul 2022 07:00

RNS Number : 8908S
Babcock International Group PLC
19 July 2022
 

19 July 2022

 

Babcock to sell part of its aerial emergency services business

 

Babcock International Group PLC (Babcock) is pleased to announce that it has entered into an agreement with funds managed by Ancala Partners, a mid-market infrastructure investor, for the sale of certain of its aerial emergency services businesses for a gross cash consideration of €136.2 million (which equates to around £115 million), subject to closing adjustments and before transaction costs.

These businesses provide aerial emergency medical services, firefighting and search & rescue to customers and communities in Italy, Spain, Portugal, Norway, Sweden and Finland. They employ over 2,400 highly trained employees and operate a fleet of 232 aircraft across 164 operational locations in the six countries. Babcock will retain its aerial emergency services businesses in its focus countries of the UK, France, Canada and Australia, where the Group also operates defence businesses.

The sale forms part of Babcock's portfolio alignment programme, designed to focus the Group and reduce complexity. Proceeds from the transaction will be retained for general corporate purposes.

Babcock CEO David Lockwood said: "The agreement marks another significant step forward in our strategy to align our portfolio. I would like to thank colleagues for their commitment and hard work in providing vital services for their customers, not least through the pandemic, and I wish them and Ancala every success for the future."

The businesses being sold are part of Babcock's Aviation sector. For the year ended 31 March 2021 they reported revenues of £407 million and a loss before tax of £177 million, including a £6 million contribution before allocated overheads, exceptional items and other one-off adjustments arising from the Contract Profitability and Balance Sheet review.

 

As of 31 March 2021, gross assets were £631 million (year ended 31 March 2020 £881 million), with net assets excluding cash of £156m and net lease liabilities of £230 million.

 

Based on unaudited figures for the year ended 2022, the businesses have recorded revenue of £405 million, and a loss before tax of £10 million (an operating profit contribution of c£13 million before allocated overheads). As of 31 March 2022, based on unaudited figures, gross assets were £635 million and net lease liabilities were £209 million.

 

Completion of the agreement is subject to certain regulatory and other conditions. The deal is expected to complete by the end of the calendar year, subject to the satisfaction of the relevant conditions.

Further information will be provided upon completion of the deal.

 

Ends

 

For further information:

 

Andrew Gollan, Babcock Director of Investor Relations

+44 (0)7936 039004

Kate Hill, Babcock Group Director of Communications

+44 (0)20 7355 5312

Olivia Peters / Harry Cameron, Tulchan Communications

+44 (0)20 7353 4200  

 

Notes to Editors

 

About Babcock

Babcock is an international aerospace, defence and security company, with a leading naval business, providing value add services across a range of countries, including the UK, France, Canada, Australia and South Africa. We help customers in the UK and around the world to improve the capability, reliability and availability of their most critical assets.

 

 

About Ancala Partners

Ancala is an experienced and entrepreneurial investor in critical mid-market infrastructure. Founded in 2010 as an independent investment manager, Ancala adopts a unique approach combining differentiated investment sourcing with active asset management.

 

Ancala invests in a broad range of infrastructure sectors, focusing on assets which have downside protection and strong earnings visibility. With an emphasis on proprietary opportunities which have arisen from unique situations, Ancala leverages deep sector knowledge and operational capabilities, combined with a strong network developed through decades of operating in the European infrastructure market, across all its investments. This enables the firm to develop assets for the long term and deliver superior value to investors.

 

For more information, please visit www.ancala.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISEAAXPFEAAEAA
Date   Source Headline
26th Apr 20241:15 pmRNSHolding(s) in Company
1st Mar 20247:00 amRNSContract awarded to refit UK nuclear submarine
21st Feb 20245:58 pmRNSDirector/PDMR Shareholding
15th Feb 20247:05 amRNSDirector announcement
14th Feb 20245:36 pmRNSDirector/PDMR Shareholding
14th Feb 20249:00 amRNSDirector appointment
9th Feb 20244:26 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNSCapital Markets Day
6th Feb 20244:58 pmRNSDirector/PDMR Shareholding
5th Feb 202411:29 amRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSAmended Capital Markets Day start time
12th Jan 20247:00 amRNSNotice of Capital Markets Day
15th Dec 20234:51 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSResults for the six months ended 30 September 2023
10th Nov 202312:00 pmRNSBabcock signs £750 million infrastructure contract
7th Nov 20233:24 pmRNSHolding(s) in Company
30th Oct 20231:55 pmRNSHolding(s) in Company
28th Sep 20236:12 pmRNSResult of AGM
28th Sep 20237:00 amRNSAGM trading update
26th Sep 20235:57 pmRNSHolding(s) in Company
26th Sep 20235:56 pmRNSHolding(s) in Company
22nd Aug 20238:54 amRNSDirector/PDMR Shareholding
17th Aug 20232:52 pmRNSNotice of AGM
16th Aug 20235:16 pmRNSDirector/PDMR Shareholding
9th Aug 202310:00 amRNSDirector/PDMR Shareholding
4th Aug 20233:24 pmRNSDirector/PDMR Shareholding
3rd Aug 20233:34 pmRNSDirector/PDMR Shareholding
3rd Aug 202310:19 amRNSDirector/PDMR Shareholding
2nd Aug 20233:25 pmRNSDirector/PDMR Shareholding
2nd Aug 202310:22 amRNSDirector/PDMR Shareholding
31st Jul 20239:22 amRNSAnnual Financial Report
20th Jul 20237:16 amRNSFull year results for the year ended 31 March 2023
11th Jul 20237:00 amRNSDate of publication of FY23 preliminary statement
24th May 20238:54 amRNSDirectorate Change
20th Apr 20237:00 amRNSFY23 post close update and Type 31 contract update
1st Mar 20237:00 amRNSDisposal programme successfully concluded
15th Feb 20239:09 amRNSBabcock awarded contract to operate Skynet
2nd Feb 20238:13 amRNSDirectorate Change
20th Dec 202212:54 pmRNSStandard & Poor credit rating upgrade
9th Dec 20229:29 amRNSHolding(s) in Company
8th Dec 20229:06 amRNSHolding(s) in Company
22nd Nov 20227:00 amRNSHalf-year Report
9th Nov 20224:48 pmRNSHolding(s) in Company
3rd Nov 202212:13 pmRNSRestatement of pass-through revenue for HY22
3rd Nov 202211:08 amRNSRestatement of H1 2022 Results
21st Oct 20228:05 amRNSContract Win
18th Oct 20229:00 amRNSDirector appointment
13th Oct 202210:41 amRNSHolding(s) in Company
26th Sep 20224:00 pmRNSResult of AGM
26th Sep 20227:00 amRNSAGM Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.